CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 242 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,180,008 | +59.6% | 43,311 | +30.3% | 0.00% | – |
Q2 2023 | $739,546 | -2.4% | 33,238 | -5.0% | 0.00% | – |
Q1 2023 | $757,667 | +6.9% | 34,980 | +0.2% | 0.00% | – |
Q4 2022 | $708,961 | -20.0% | 34,907 | +1.0% | 0.00% | -100.0% |
Q3 2022 | $885,965 | +6.1% | 34,554 | -1.6% | 0.00% | 0.0% |
Q2 2022 | $834,844 | +0.5% | 35,107 | -4.8% | 0.00% | 0.0% |
Q1 2022 | $830,853 | -14.6% | 36,894 | -24.9% | 0.00% | 0.0% |
Q4 2021 | $973,000 | -1.2% | 49,147 | -1.8% | 0.00% | 0.0% |
Q3 2021 | $985,000 | -18.8% | 50,067 | -9.2% | 0.00% | 0.0% |
Q2 2021 | $1,213,000 | -7.5% | 55,130 | -0.1% | 0.00% | 0.0% |
Q1 2021 | $1,312,000 | -14.2% | 55,160 | -5.6% | 0.00% | 0.0% |
Q4 2020 | $1,529,000 | +56.8% | 58,462 | +4.4% | 0.00% | 0.0% |
Q3 2020 | $975,000 | +0.9% | 55,996 | -2.9% | 0.00% | 0.0% |
Q2 2020 | $966,000 | +32.7% | 57,671 | -5.8% | 0.00% | 0.0% |
Q1 2020 | $728,000 | +4.0% | 61,210 | +5.8% | 0.00% | 0.0% |
Q4 2019 | $700,000 | -83.8% | 57,858 | -80.4% | 0.00% | -80.0% |
Q3 2019 | $4,314,000 | +527.9% | 295,877 | +379.9% | 0.01% | +400.0% |
Q2 2019 | $687,000 | -83.0% | 61,658 | -82.1% | 0.00% | -75.0% |
Q1 2019 | $4,040,000 | -12.1% | 344,152 | +0.1% | 0.00% | -33.3% |
Q4 2018 | $4,594,000 | -15.6% | 343,838 | -11.4% | 0.01% | 0.0% |
Q3 2018 | $5,441,000 | +3.0% | 388,114 | +15.5% | 0.01% | 0.0% |
Q2 2018 | $5,282,000 | +10.3% | 336,031 | +15.5% | 0.01% | +20.0% |
Q1 2018 | $4,787,000 | +12.0% | 290,991 | +22.9% | 0.01% | 0.0% |
Q4 2017 | $4,275,000 | +23.1% | 236,728 | +31.5% | 0.01% | +25.0% |
Q3 2017 | $3,473,000 | +62.3% | 179,974 | -0.8% | 0.00% | +33.3% |
Q2 2017 | $2,140,000 | +225.2% | 181,414 | +201.7% | 0.00% | +200.0% |
Q1 2017 | $658,000 | +70.9% | 60,122 | +13.4% | 0.00% | 0.0% |
Q4 2016 | $385,000 | +9.7% | 53,008 | -1.7% | 0.00% | 0.0% |
Q3 2016 | $351,000 | +19.4% | 53,940 | +0.2% | 0.00% | – |
Q2 2016 | $294,000 | +53.9% | 53,837 | +20.7% | 0.00% | – |
Q1 2016 | $191,000 | -12.0% | 44,605 | +2.1% | 0.00% | – |
Q4 2015 | $217,000 | +36.5% | 43,668 | +2.9% | 0.00% | – |
Q3 2015 | $159,000 | -37.6% | 42,441 | 0.0% | 0.00% | – |
Q2 2015 | $255,000 | +9.4% | 42,441 | +1.9% | 0.00% | – |
Q1 2015 | $233,000 | +87.9% | 41,668 | +0.8% | 0.00% | – |
Q4 2014 | $124,000 | +15.9% | 41,355 | +3.6% | 0.00% | – |
Q3 2014 | $107,000 | +1683.3% | 39,920 | +1889.0% | 0.00% | – |
Q2 2014 | $6,000 | -97.0% | 2,007 | -95.6% | 0.00% | – |
Q1 2014 | $200,000 | +50.4% | 45,749 | +10.5% | 0.00% | – |
Q4 2013 | $133,000 | +1377.8% | 41,408 | +667.5% | 0.00% | – |
Q3 2013 | $9,000 | -25.0% | 5,395 | -21.8% | 0.00% | – |
Q2 2013 | $12,000 | – | 6,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 8,609,429 | $55,961,000 | 3.12% |
INVESTOR AB | 1,835,974 | $11,934,000 | 0.86% |
GLOBEFLEX CAPITAL L P | 244,183 | $1,587,000 | 0.40% |
Campbell & CO Investment Adviser LLC | 21,446 | $139,000 | 0.37% |
Birchview Capital, LP | 80,000 | $520,000 | 0.30% |
FEDERATED HERMES, INC. | 13,879,968 | $90,220,000 | 0.26% |
MENTA CAPITAL LLC | 388,582 | $2,526,000 | 0.24% |
Sitrin Capital Management LLC | 40,000 | $260,000 | 0.20% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 172,389 | $1,121,000 | 0.18% |
GSA CAPITAL PARTNERS LLP | 384,976 | $2,502,000 | 0.13% |